top of page
Foot and beach

References

​1. Br J Dermatol. 2014;171(5):937-958.


2. Thomas et al. J Clin Pharm Ther. 2010 Oct; 35(5):497-519.


3. Elewski et al. J Am Acad Dermatol. 2013;68(4):600-608.


4. JUBLIA® Prescribing Information.


5. Data on File. Confidential company data.

6. Lipner et al. J Drugs Dermatol. 2021;20(10)

7. Gupta et al. J Cutan Med Surg 2015; 19(5):440-9

8. Park et al. JMI 2018; 23(2):33-44

9. Foley et al. Cochrane Library 2020: Topical and device-based treatments for fungal infections of the toenails (Review)

10. Sugiura et al. Antimicrob Agents and Chemother. 2014; 58(7):3837-42

11. Tosti and Elewski. Skin Appendage Disord. 2016; 2:83-87

JUBLIA®︎ is a prescription drug. The effectiveness and side effects of the medication may vary among individuals. Please consult your doctor or pharmacist for more information.

Disclaimer

All rights reserved. © 2020 Main Life Corp., Ltd.

The product information provided in this site is intended for residents of Hong Kong.

The health information is provided for reference only and is not intended to replace discussions with a healthcare provider.

All decisions regarding patient care must be made with healthcare provider.

JUBLIA® is a registered trademark of Kaken Pharmaceutical Co., Ltd.

bottom of page